Cleared Traditional

K821363 - TRANS-Q

K821363 is an FDA 510(k) clearance for TRANS-Q, manufactured by Chesapeake Medical Assoc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 21-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1982
Decision
21d
Days
Class 2
Risk

K821363 is an FDA 510(k) clearance for the TRANS-Q. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Chesapeake Medical Assoc. (Mchenry, US). The FDA issued a Cleared decision on May 28, 1982 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K821363

510(k) Number K821363 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 1982
Decision Date May 28, 1982
Days to Decision 21 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
128d faster than avg
Panel avg: 149d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K821363.
NEUROMEDICS ORIONS #660-01
K822600 · Intermedics, Inc. · Sep 1982
TP440 ORTHOPROBE
K821571 · Grove Video Corp. · Jul 1982
OMNI TENS
K821523 · Omni Intl., Inc. · Jun 1982
BIGSTON TRANSCUTANEOUS NERVE STIMULAT
K820326 · Canadian Medical Products · Apr 1982
MODEL 860-1 VERI/PROBE
K820651 · Verite · Apr 1982
SYSTEM 10
K820678 · Biostim, Inc. · Mar 1982